| Autoimmune Bullous Skin Diseases | Lifetime | 145 | IT 10 | 98.65 |
| Urticaria and Related Conditions | Lifetime | 173 | IT 13 | 98.25 |
| Dermatological and COVID-19 studies | Lifetime | 37 | IT 2 | 96.96 |
| Skin Diseases and Diabetes | Lifetime | 65 | IT 4 | 97.95 |
| Dermatological and Skeletal Disorders | Lifetime | 135 | IT 10 | 97.06 |
| Drug-Induced Adverse Reactions | Lifetime | 215 | IT 8 | 96.78 |
| Systemic Sclerosis and Related Diseases | Lifetime | 385 | IT 45 | 97.14 |
| Oral Health Pathology and Treatment | Lifetime | 331 | IT 16 | 97.07 |
| Dermatologic Treatments and Research | Lifetime | 316 | IT 16 | 96.88 |
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 227 | IT 21 | 96.86 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 407 | IT 42 | 96.89 |
| Eosinophilic Disorders and Syndromes | Lifetime | 530 | IT 47 | 96.30 |
| Autoimmune and Inflammatory Disorders | Lifetime | 263 | IT 17 | 96.22 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 550 | IT 33 | 96.08 |
| Acne and Rosacea Treatments and Effects | Lifetime | 200 | IT 7 | 95.91 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 518 | IT 49 | 95.43 |
| Genetic and rare skin diseases. | Lifetime | 238 | IT 21 | 94.89 |
| Parvovirus B19 Infection Studies | Lifetime | 768 | IT 48 | 93.14 |
| Contact Dermatitis and Allergies | Lifetime | 936 | IT 63 | 93.57 |
| Hair Growth and Disorders | Lifetime | 449 | IT 18 | 92.07 |
| Hidradenitis Suppurativa and Treatments | Lifetime | 409 | IT 45 | 82.30 |
| Sympathectomy and Hyperhidrosis Treatments | Lifetime | 903 | IT 94 | 80.68 |
| Tattoo and Body Piercing Complications | Lifetime | 264 | IT 6 | 72.08 |
| Dermatological and COVID-19 studies | 2021-2025 | 4 | IT 3 | 97.28 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 39 | IT 3 | 98.32 |
| Dermatology and Skin Diseases | 2021-2025 | 221 | IT 31 | 96.78 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 147 | IT 27 | 96.99 |
| Acne and Rosacea Treatments and Effects | 2021-2025 | 95 | IT 6 | 90.44 |
| Urticaria and Related Conditions | 2021-2025 | 262 | IT 21 | 90.55 |
| Contact Dermatitis and Allergies | 2021-2025 | 314 | IT 24 | 84.97 |
| Drug-Induced Adverse Reactions | 2021-2025 | 295 | IT 23 | 84.09 |
| Oral Health Pathology and Treatment | 2021-2025 | 506 | IT 58 | 81.15 |
| Hidradenitis Suppurativa and Treatments | 2021-2025 | 169 | IT 32 | 82.87 |
| Nail Diseases and Treatments | 2021-2025 | 449 | IT 26 | 81.13 |
| Parvovirus B19 Infection Studies | 2021-2025 | 317 | IT 36 | 74.16 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 742 | IT 75 | 75.55 |
| Autoimmune and Inflammatory Disorders | 2021-2025 | 440 | IT 43 | 72.97 |
| Genital Health and Disease | 2021-2025 | 885 | IT 100 | 71.60 |
| Mast cells and histamine | 2021-2025 | 516 | IT 41 | 73.92 |
| Nonmelanoma Skin Cancer Studies | 2021-2025 | 916 | IT 113 | 73.49 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 744 | IT 70 | 73.16 |
| Cancer and Skin Lesions | 2021-2025 | 753 | IT 84 | 68.21 |
| Dermatological and Skeletal Disorders | 2021-2025 | 270 | IT 50 | 67.55 |
| Skin Diseases and Diabetes | 2021-2025 | 233 | IT 27 | 67.03 |
| Bacillus and Francisella bacterial research | 2021-2025 | 938 | IT 69 | 63.88 |
| Dermatological diseases and infestations | 2021-2025 | 321 | IT 18 | 64.11 |
| Syphilis Diagnosis and Treatment | 2021-2025 | 786 | IT 10 | 62.53 |
| Genetic and rare skin diseases. | 2021-2025 | 583 | IT 59 | 46.08 |
